LMO4 Antibodies

Santa Cruz Biotechnology provides a broad selection of LMO4 monoclonal antibodies for research focused on understanding LMO4 protein functions. LMO4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LMO4, or LIM domain only 4, is a crucial protein involved in the regulation of gene expression and plays a significant role in neural development and differentiation. LMO4 dysregulation has been implicated in various cancers, making it an important target for therapeutic research. Understanding LMO4 functions can provide insights into developmental biology and potential disease mechanisms. Research with LMO4 monoclonal antibodies enables exploration of neural development pathways and cancer biology. Investigating LMO4 expression patterns and interactions helps reveal its role in cellular processes and disease progression. Santa Cruz Biotechnology monoclonal antibodies for LMO4 support researchers worldwide in advancing scientific understanding of neural development and cancer biology.